Literature DB >> 22290140

Cerebral and muscle MRI abnormalities in myotonic dystrophy.

Daniel T Franc1, Ryan L Muetzel, Paul R Robinson, Craig P Rodriguez, Joline C Dalton, Cameron E Naughton, Bryon A Mueller, Jeffrey R Wozniak, Kelvin O Lim, John W Day.   

Abstract

Pathophysiological mechanisms underlying the clinically devastating CNS features of myotonic dystrophy (DM) remain more enigmatic and controversial than do the muscle abnormalities of this common form of muscular dystrophy. To better define CNS and cranial muscle changes in DM, we used quantitative volumetric and diffusion tensor MRI methods to measure cerebral and masticatory muscle differences between controls (n=5) and adults with either congenital (n=5) or adult onset (n=5) myotonic dystrophy type 1 and myotonic dystrophy type 2 (n=5). Muscle volumes were diminished in DM1 and strongly correlated with reduced white matter integrity and gray matter volume. Moreover, correlation of reduced fractional anisotropy (white matter integrity) and gray matter volume in both DM1 and DM2 suggests that these abnormalities may share a common underlying pathophysiological mechanism. Further quantitative temporal and spatial characterization of these features will help delineate developmental and progressive neurological components of DM, and help determine the causative molecular and cellular mechanisms.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22290140      PMCID: PMC3350604          DOI: 10.1016/j.nmd.2012.01.003

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  44 in total

Review 1.  Advances in functional and structural MR image analysis and implementation as FSL.

Authors:  Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

2.  Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy.

Authors:  G Meola; V Sansone; D Perani; A Colleluori; S Cappa; M Cotelli; F Fazio; C A Thornton; R T Moxley
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

3.  Anterior temporal white matter lesions in myotonic dystrophy with intellectual impairment: an MRI and neuropathological study.

Authors:  A Ogata; S Terae; M Fujita; K Tashiro
Journal:  Neuroradiology       Date:  1998-07       Impact factor: 2.804

4.  Brain MRI features of congenital- and adult-form myotonic dystrophy type 1: case-control study.

Authors:  Alfonso Di Costanzo; Francesco Di Salle; Lucio Santoro; Vincenzo Bonavita; Gioacchino Tedeschi
Journal:  Neuromuscul Disord       Date:  2002-06       Impact factor: 4.296

5.  Subtle cognitive dysfunction in adult onset myotonic dystrophy type 1 (DM1) and type 2 (DM2).

Authors:  C Gaul; T Schmidt; G Windisch; T Wieser; T Müller; S Vielhaber; S Zierz; B Leplow
Journal:  Neurology       Date:  2006-07-25       Impact factor: 9.910

6.  White matter lesions and cognitive deficits: relevance of lesion pattern?

Authors:  M S Damian; G Schilling; G Bachmann; C Simon; S Stöppler; W Dorndorf
Journal:  Acta Neurol Scand       Date:  1994-12       Impact factor: 3.209

7.  Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy.

Authors:  Thurman M Wheeler; John D Lueck; Maurice S Swanson; Robert T Dirksen; Charles A Thornton
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

8.  Cognitive function in early adult and adult onset myotonic dystrophy.

Authors:  K P Van Spaendonck; J P Ter Bruggen; E W Weyn Banningh; B A Maassen; J B Van de Biezenbos; F J Gabreëls
Journal:  Acta Neurol Scand       Date:  1995-06       Impact factor: 3.209

9.  Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

Authors:  J D Brook; M E McCurrach; H G Harley; A J Buckler; D Church; H Aburatani; K Hunter; V P Stanton; J P Thirion; T Hudson
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

10.  Quantification of brain atrophy in patients with myotonic dystrophy and proximal myotonic myopathy: a controlled 3-dimensional magnetic resonance imaging study.

Authors:  Jan Kassubek; Freimut D Juengling; Stefanie Hoffmann; Angela Rosenbohm; Anja Kurt; Karin Jurkat-Rott; Peter Steinbach; Michael Wolf; Albert C Ludolph; Frank Lehmann-Horn; Holger Lerche; Yvonne G Weber
Journal:  Neurosci Lett       Date:  2003-09-11       Impact factor: 3.046

View more
  26 in total

1.  Diagnostic odyssey of patients with myotonic dystrophy.

Authors:  James E Hilbert; Tetsuo Ashizawa; John W Day; Elizabeth A Luebbe; William B Martens; Michael P McDermott; Rabi Tawil; Charles A Thornton; Richard T Moxley
Journal:  J Neurol       Date:  2013-06-27       Impact factor: 4.849

2.  Repeat-associated non-ATG (RAN) translation.

Authors:  John Douglas Cleary; Amrutha Pattamatta; Laura P W Ranum
Journal:  J Biol Chem       Date:  2018-09-13       Impact factor: 5.157

3.  Brain MRI abnormalities in the adult form of myotonic dystrophy type 1: A longitudinal case series study.

Authors:  Renata Conforti; Mario de Cristofaro; Adriana Cristofano; Barbara Brogna; Angela Sardaro; Gioacchino Tedeschi; Sossio Cirillo; Alfonso Di Costanzo
Journal:  Neuroradiol J       Date:  2016-01-11

4.  Tractography reveals diffuse white matter abnormalities in Myotonic Dystrophy Type 1.

Authors:  Jeffrey R Wozniak; Bryon A Mueller; Kelvin O Lim; Laura S Hemmy; John W Day
Journal:  J Neurol Sci       Date:  2014-04-13       Impact factor: 3.181

5.  Frontostriatal dysexecutive syndrome: a core cognitive feature of myotonic dystrophy type 2.

Authors:  Stojan Peric; Gorana Mandic-Stojmenovic; Elka Stefanova; Dusanka Savic-Pavicevic; Jovan Pesovic; Vera Ilic; Valerija Dobricic; Ivana Basta; Dragana Lavrnic; Vidosava Rakocevic-Stojanovic
Journal:  J Neurol       Date:  2014-10-28       Impact factor: 4.849

6.  Longitudinal study in patients with myotonic dystrophy type 1: correlation of brain MRI abnormalities with cognitive performances.

Authors:  T Cabada; J Díaz; M Iridoy; P López; I Jericó; P Lecumberri; B Remirez; R Seijas; M Gomez
Journal:  Neuroradiology       Date:  2020-11-25       Impact factor: 2.804

7.  Evaluation of CNS involvement in myotonic dystrophy type 1 and type 2 by transcranial sonography.

Authors:  Christos Krogias; Barbara Bellenberg; Christian Prehn; Ruth Schneider; Saskia H Meves; Ralf Gold; Carsten Lukas; Christiane Schneider-Gold
Journal:  J Neurol       Date:  2014-11-11       Impact factor: 4.849

8.  MRI findings and cognitive functions in a small cohort of myotonic dystrophy type 1: Retrospective analyses.

Authors:  Arsida Bajrami; Filiz Azman; Vildan Yayla; Sultan Cagirici; Cahit Keskinkiliç; Nejla Sozer
Journal:  Neuroradiol J       Date:  2016-11-11

Review 9.  Recent advances in myotonic dystrophy type 2.

Authors:  Christina M Ulane; Sarah Teed; Jacinda Sampson
Journal:  Curr Neurol Neurosci Rep       Date:  2014-02       Impact factor: 5.081

10.  How genetics affects the brain to produce higher-level dysfunctions in myotonic dystrophy type 1.

Authors:  Laura Serra; Antonio Petrucci; Barbara Spanò; Mario Torso; Giusy Olivito; Ludovico Lispi; Sandro Costanzi-Porrini; Giovanni Giulietti; Giacomo Koch; Manlio Giacanelli; Carlo Caltagirone; Mara Cercignani; Marco Bozzali
Journal:  Funct Neurol       Date:  2015 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.